Lattice corneal dystrophy type II
Última actualización 18 Aug 2020
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Ask Patient
- Versión en audio
- Agregar a fuentes preferidas en Google
Lattice corneal dystrophy type II is characterised by an accumulation of protein clumps called amyloid deposits in tissues throughout the body. The deposits frequently occur in blood vessel walls and basement membranes, which are thin, sheet-like structures that separate and support cells in many tissues. Amyloid deposits lead to characteristic signs and symptoms involving the eyes, nerves, and skin that worsen with age.
Selecciones de videos para Condiciones genéticasBiblioteca de videos
Descripción
Lattice corneal dystrophy type II is characterised by an accumulation of protein clumps called amyloid deposits in tissues throughout the body. The deposits frequently occur in blood vessel walls and basement membranes, which are thin, sheet-like structures that separate and support cells in many tissues. Amyloid deposits lead to characteristic signs and symptoms involving the eyes, nerves, and skin that worsen with age.
The earliest sign of this condition, which is usually identified in a person's twenties, is accumulation of amyloid deposits in the cornea (lattice corneal dystrophy). The cornea is the clear, outer covering of the eye. It is made up of several layers of tissue, and in lattice corneal dystrophy type II, the amyloid deposits form in the stromal layer. The amyloid deposits form as delicate, branching fibers that create a lattice pattern. Because these protein deposits cloud the cornea, they often lead to vision impairment. In addition, affected individuals can have recurrent corneal erosions, which are caused by separation of particular layers of the cornea from one another. Corneal erosions are very painful and can cause sensitivity to bright light (photophobia). Amyloid deposits and corneal erosions are usually bilateral, which means they affect both eyes.
As lattice corneal dystrophy type II progresses, the nerves become involved, typically starting in a person's forties. It is thought that the amyloid deposits disrupt nerve function. Dysfunction of the nerves in the head and face (cranial nerves) can cause paralysis of facial muscles (facial palsy); decreased sensations in the face (facial hypoesthesia); and difficulty speaking, chewing, and swallowing. Dysfunction of the nerves that connect the brain and spinal cord to muscles and to sensory cells that detect sensations such as touch, pain, and heat (peripheral nerves) can cause loss of sensation and weakness in the limbs (peripheral neuropathy). Peripheral neuropathy usually occurs in the lower legs and arms, leading to muscle weakness, clumsiness, and difficulty sensing vibrations.
The skin is also commonly affected in people with lattice corneal dystrophy type II, typically beginning in a person's forties. People with this condition may have thickened, sagging skin, especially on the scalp and forehead, and a condition called cutis laxa, which is characterised by loose skin that lacks elasticity. The skin can also be dry and itchy. Because of loose skin and muscle paralysis in the face, individuals with lattice corneal dystrophy type II can have a facial expression that appears sad.
Patrones de herencia
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Otros nombres
Amyloid cranial neuropathy with lattice corneal dystrophy
Amyloidosis due to mutant gelsolin
Amyloidosis V
Amyloidosis, Finnish type
Amyloidosis, Meretoja type
Familial amyloid polyneuropathy type IV
Familial amyloidosis, Finnish type
Gelsolin-related amyloidosis
Kymenlaakso syndrome
Lattice corneal dystrophy, gelsolin type
Meretoja syndrome
Related patient information and medicines

Patient information leaflet
Problemas oculares
See the leaflet called Anatomy. Eye s... Distrofias corneales These are a grupo of progressive conditions which cause a build-up of cloudy material in the cornea. Consulte el folleto separado titulado Problemas visuales. Retinal dystrophy Retinal dystrophies are a group of inherited disorders which result in changes to the retina, which may affect vision;.

Patient information leaflet
Problemas visuales
¿Qué es visual loss. Visual loss can be partial (meaning the vi... There is currently no treatment which stops the progress of the condition, although complete loss of vision is uncommon. Retinal dystrophy Retinal dystrophies are a group of inherited (genetic) disorders which result in changes to the retina which may affect vision. They are fairly.
/og.png)
Patient information leaflet
Infección ocular (herpes simple)
A herpes simplex eye infection, or eye herpes, is a viral infection caused by the herpes simplex virus (HSV). Key points A herpes simplex eye infection es an infection of the eye, usually the cornea. ... herpes simplex eye infectionsDr Sarah Jarvis MBE For more information on eye problems, go to.

Patient information leaflet
Enfermedad ósea de Paget
Paget's disease of bone affects the structure of parts of one or more bones. In most cases it causes no symptoms and does not need treatment. Symptoms develop in some cases and pain in the affected part of bone is the most common symptom. A... There is a slow but constant turnover of bone. What is Paget's disease of bone. Paget's disease of bone.

Patient information leaflet
Trastornos del almacenamiento de glucógeno
Symptoms include weakness. Newer treatment possibilities provide hope for an improved outlook (prognosis). Most people with a glycogen storage disorder respond well to treatment. However, type II (infantile Pompe's disease) can be difficult to treat and can affect life expectancy. What is glycogen. Your body needs the sugar glucose to provide.

Patient information leaflet
Pruebas genéticas
Pruebas genéticas is a type of medical test that identifies changes in chromosomes, genes or proteins. Genetic tests examine a person's DNA in a variety of ways to assess a person's genetic health. Fluorescent in situ hybridisation (FISH) analysis - this test looks at certain parts of the chromosomes and can detect very small pieces of chromosomes.
Lecturas adicionales y referencias
- Lattice corneal dystrophy type II; MedlinePlus, National Library of Medicine.
- Carrwik C, Stenevi U. Lattice corneal dystrophy, gelsolin type (Meretoja's syndrome). Acta Ophthalmol. 2009 Nov;87(8):813-9. doi: 10.1111/j.1755-3768.2009.01686.x.
- Klintworth GK. Corneal dystrophies. Orphanet J Rare Dis. 2009 Feb 23;4:7. doi: 10.1186/1750-1172-4-7.
- Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, Prelli F, Frangione B. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med. 1990 Dec 1;172(6):1865-7. doi: 10.1084/jem.172.6.1865.
- Paunio T, Kangas H, Kalkkinen N, Haltia M, Palo J, Peltonen L. Toward understanding the pathogenic mechanisms in gelsolin-related amyloidosis: in vitro expression reveals an abnormal gelsolin fragment. Hum Mol Genet. 1994 Dec;3(12):2223-9. doi: 10.1093/hmg/3.12.2223.
Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.
Suscríbete al boletín de Patient
Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.

